Definitive radiotherapy is the standard treatment for head and neck squamous cell carcinoma, but it often leads to significant long-term side effects, particularly from elective neck irradiation.

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain head and neck cancers from returning. Continuous use of Keytruda ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival ...

Evorpacept has received FDA fast track and orphan drug designations for HER-2 positive gastric or GEJ carcinoma. In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet ...

“My head and neck would not move for four hours this morning. I could not get out of my bed,” Glanville, 52, wrote via X on Tuesday, April 22. “I called 911, had a lovely trip in the ambulanc ...

LITTLE ROCK, Ark. (KATV) — April is head and neck cancer awareness month, a time dedicated to raising awareness about a group of cancers that often go unnoticed until it's too late. These ...

head coach Ryan Day said. “Lincoln and Julian are, you know, pretty much neck-and-neck right now,” Day said in comments to reporters. St. Clair is the former No. 3 quarterback, fourth-best ...

Head and neck cancers represent 4% of U.S. cancer cases, with significant mortality rates, highlighting the need for awareness and early detection. These cancers affect multiple anatomical sites, ...

Coffee and tea consumption may be associated with a reduced risk of head and neck cancer, a new analysis suggests. Head and neck cancer, referring to cancers of the oral cavity, pharynx ...

Share on Pinterest Scientists have found a link between drinking coffee or tea and head and neck cancer risk. Tatiana Maksimova/Getty Images Prevention is a key component of addressing the impact ...

The study, led by Nader Sadeghi, MD, McGill University Health Centre, Montreal, Canada, published online in JAMA Otolaryngology-Head & Neck Surgery. Patients considered unfavorable for transoral ...

Please provide your email address to receive an email when new articles are posted on . Patients who received nivolumab had longer DFS than those who received standard care. OS will be evaluated ...